课题基金 / 基金详情

Pthophysiological significance of target genes of NRSF, a new transcriptional suppressor, in congestive heart failure

Pthophysiological significance of target genes of NRSF, a new transcriptional suppressor, in congestive heart failure
新型转录抑制因子 NRSF 靶基因在充血性心力衰竭中的生理学意义
批准号:
18390238
负责人:
SAITO Yoshihiko
金额:
$11.36万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

SAITO Yoshihiko的其他基金

相似基金

相关文献

中文摘要
翻译
醛固酮是参与心力衰竭发病机制的关键分子之一,由肾上腺皮质细胞特异性合成酶CYP 11B 2合成,其基因表达受T型钙通道Cav 3.2介导的钙内流调控。最近我们报道了神经元限制性沉默因子(Neuron restrictive silencer factor,NRSF)与神经元限制性沉默元件(Neuron restrictive silencer element,NRSE)结合,抑制含NRSE基因的转录,并参与体内外心脏胚胎基因的再诱导。过表达显性负性NRSF的小鼠表现出扩张性心肌病样心脏表型改变和致死性室性心律失常引起的心源性猝死,我们还鉴定了与NRSE序列高度同源的序列位于CYP 11B 2基因和CACNA 1H基因的转录调控区,后者编码Cav3.2的亚基。本实验研究了NRSE/NRSF系统在人肾上腺皮质细胞(H295 R)合成醛固酮中的作用。腺病毒载体介导的显性负性NRSF(AD/dnNRSF)抑制内源性NRSF功能可显著增加醛固酮分泌和CYP 11B 2 mRNA的表达。AD/dnNRSF还增加CACNA 1H mRNA的水平。Efonidipine,双重T/L型钙通道阻滞剂,抑制dnNRSF诱导的CYP 11B 2 mRNA表达和CYP 11B 2报告基因活性的结构含有突变或缺失的NRSE序列。AD/dnNRSF可抑制Ang Ⅱ和K^+诱导的CYP 11 B2 mRNA表达的增加,提示NRSE/NRSF系统调控肾上腺醛固酮合成,是心力衰竭的心外代偿机制之一。
英文摘要
Aldosterone, one of key molecules which are involved in pathogenesis in heart failure, is synthesized by a specific synthase, CYP11B2, and its gene expression is regulated Ca influx into via T-type calcium channel, Cav 3.2, in adrenal cortical cells. However, the molecular mechanism for aldosterone synthesis in heart failure is not fully understood.Recently we reported that Neuron restrictive silencer factor (NRSF), which binds to neuron restrictive silencer element (NRSE) to suppress transcription of NRSE-containing genes, is involved in the re-induction of a number of cardiac embryonic genes in vitro and in vivo. Mice over-expressing dominant negative NRSF show dilated cardiomyopathy-like cardiac phenotypic changes and sudden cardiac death due to fatal ventricular arrhythmia.We also identified the sequence highly homologous to NRSE sequence is located in transcriptional regulatory region of the CYP11B2 gene and CACNA1H gene, the latter of which encodes subunit of Cav3.2.Here we examined the roles of the NRSE/NRSF system in aldosterone synthesis in human adrenocortical (H295R) cells. Inhibiting endogenous NRSF function by adenovirus vector containing dominant-negative NRSF (AD/dnNRSF) markedly increased aldosterone secretion and CYP11B2 mRNA. AD/dnNRSF also increased levels of CACNA1H mRNA. Efonidipine, dual T/L-type calcium channel blocker, inhibited dnNRSF-induced CYP11B2 mRNA expression and CYP11B2 reporter gene activity from constructs containing a mutated or missing NRSE sequence. Moreover, AD/dnNRSF attenuated AngII- and K^+-induced increases in CYP11B2 mRNA levels.The present findings suggest the NRSE/NRSF system controls aldosterone synthesis in the adrenal gland, which is one of extracardiac compensatory mechanism in heart failure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic disruption of angiotensin II type la receptor improves long-term survival of mice with chronic severe aortic regurgitation
血管紧张素II 1a型受体的基因破坏可改善患有慢性严重主动脉瓣反流的小鼠的长期存活率
DOI: --
发表时间: 2007
期刊: Circ J 71
影响因子: --
作者: [M.Nakanishi, M.Harada, et. al.]
通讯作者: et. al.
Prasma level of soluble fms-like tyrosine kinase 1(sFlt-1)as a predictive marker of acute severe heart failure in patients with acute myocardial infarction.
可溶性 fms 样酪氨酸激酶 1 (sFlt-1) 的 Prasma 水平作为急性心肌梗死患者急性严重心力衰竭的预测标志物。
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Onoue K, 他]
通讯作者: 他
DOI: 10.1159/000095595
发表时间: 2007-01-01
期刊: CARDIOLOGY
影响因子: 1.9
作者: [Mizuno, Reiko, Fujimoto, Shinichi, Nakamura, Shinobu]
通讯作者: Nakamura, Shinobu
ANP is cleard much faster than BNP in patients with congestiveheart failure
在充血性心力衰竭患者中,ANP 的清除速度比 BNP 快得多
DOI: --
发表时间: 2007
期刊: Eur J CIin Pharmacol 63
影响因子: --
作者: [K.Kimura, Y.Yamaguchi, et. al.]
通讯作者: et. al.
共 36 条
    Identifying a factor contributing to gender difference in familial dilated cardiomyopathy
    • 批准号:
      25670393
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      SAITO Yoshihiko
    • 依托单位:
    Identifying a novel gene contributing to vascular maturation and its significance in cardiovascular diseases.
    • 批准号:
      23659424
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2011
    • 负责人:
      SAITO Yoshihiko
    • 依托单位:
    Study for Molecular mechanism of cardiorenal connection.
    • 批准号:
      20390227
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2008
    • 负责人:
      SAITO Yoshihiko
    • 依托单位:
    Involvement of NRSF-mediated Transcriptional Silencing System in Molecular Mechanism of Chronic Heart Failure
    • 批准号:
      16390228
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      2004
    • 负责人:
      SAITO Yoshihiko
    • 依托单位:
    国内基金
    海外基金
    NRSF参与脊髓损伤致神经病理性痛的机制及其上下游调控
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      朱超
    • 依托单位:
    REST/NRSF调控染色质三维结构影响神经元分化的分子机制
    • 批准号:
      32200420
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      汤元霄
    • 依托单位:
    LncRNA-MRAK159688通过REST/NRSF介导 MOR表达下调参与吗啡耐受形成的分子机制研究
    • 批准号:
      81974172
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2019
    • 负责人:
      邹望远
    • 依托单位:
    NRSF介导的μ阿片受体表达调控参与骨癌痛的机制及相关镇痛策略研究
    • 批准号:
      81870885
    • 项目类别:
      面上项目
    • 资助金额:
      56.0万元
    • 批准年份:
      2018
    • 负责人:
      朱超
    • 依托单位: